"We are optimistic about a rapid review and are eager to initiate our Phase 3b study, which we are undertaking to support regulatory approval." The Phase 3b trial is expected to enroll ...

Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the ...

This important milestone sets the stage for the initiation of BrainStorm's highly anticipated Phase 3b clinical trial, which has been designed in collaboration with the FDA under a Special ...

Johnson & Johnson announced that the Tremfya Phase 3b APEX study achieved both its primary endpoint of reducing signs and symptoms and its major secondary endpoint of reducing progression of ...

Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that the last patient completed their final visit in the Whistler Phase 3b clinical ...

(RTTNews) - Drug major Johnson & Johnson (JNJ) announced Friday positive results from the TREMFYA (guselkumab) Phase 3b APEX study in adults living with active psoriatic arthritis or PsA ...

JNJ said that Tremfya, which is already approved in the U.S. for PsA, reached the main goal and a critical secondary endpoint in its Phase 3b APEX study involving patients with active PsA.

This important milestone sets the stage for the initiation of BrainStorm's highly anticipated Phase 3b clinical trial, which has been designed in collaboration with the FDA under a Special ...

Johnson & Johnson announced that the Tremfya (guselkumab) phase 3b APEX study achieved both its primary endpoint (ACR20a) of reducing signs and symptoms and its major secondary endpoint of reducing ...

The projects, estimated to cost ₹12,500 crore, are part of phase 3B of the Mumbai Urban Transport Project (MUTP). Navi Mumbai, India - December 31, 2021: Central Railway cancels AC local train ...